A new paper and other recent evidence offer important reassurances about the risk of breast cancer from hormone therapy to treat menopause symptoms, two University of Virginia School of Medicine menopause experts say.
Aug 24, 2022
0
57
A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, finds that menopausal hormone therapy for breast cancer survivors is not associated with breast cancer reoccurrence, despite ...
Jul 20, 2022
0
8
A new paper in Family Practice, published by Oxford University Press, indicates that receiving hormone replacement therapy within six months of a recorded diagnosis of COVID-19 was associated with a reduction in mortality ...
May 17, 2022
0
9
April is IBS Awareness Month, which makes this a good time to learn about irritable bowel syndrome, or IBS.
Apr 13, 2022
0
2
A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from ...
Mar 20, 2022
0
94
An experimental hormone therapy pill can effectively stall the progression of breast cancer, even in older patients whose tumors have mutated to make such therapy less effective, new trial results show.
Dec 7, 2021
0
4
Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat diet further exacerbates the disease, which can progress to cirrhosis and liver failure. ...
Oct 28, 2021
0
36
Though the two main histological types of breast cancer—lobular and ductal—are treated with the same hormonal therapies, women with lobular breast cancer often have recurrence or metastasis of the disease several years ...
Jul 28, 2021
0
4
A study led by scientists at Sanford Burnham Prebys Medical Discovery Institute has identified a tumor marker that may be used to predict which breast cancer patients will experience resistance to endocrine therapy. The research ...
May 19, 2021
0
41
Researchers at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) hope to make estrogen therapy a more accessible treatment option for breast cancer patients who could benefit from it. Anti-estrogen ...
Apr 24, 2021
0
73
